Market Valuation & Earnings Multiples
Market capitalization, P/E ratios, and enterprise value
Market Cap21.28B
Enterprise Value31.57B
Trailing P/E15.71
Forward P/E30.66
THC
(NYSE)Tenet Healthcare Corporation
$234.25-- (--)
Loading... - Market loading
Tenet Healthcare (THC) Key Statistics & Financial Metrics
Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.
Stock Valuation Metrics
Market value, earnings multiples, and pricing ratios
Price-Based Ratios
Valuation ratios based on stock price
Price/Sales (ttm)1.02
Forward Price/Sales1.01
Price/Book (mrq)5.04
Price/FCF (ttm)9.84
Price/OCF (ttm)8.59
Enterprise Value Ratios
EV-based valuation multiples
EV/Revenue1.51
EV/Earnings23.31
EV/EBITDA3.61
EV/EBIT3.98
EV/FCF14.60
Stock Price
Current price, 52-week range, and moving averages
Current Price$234.25
1-Day Change1.36%
52-Week High$235.77
52-Week Low$109.82
52-Week Change75.72%
YTD Change17.45%
1-Year Change73.63%
50-Day MA$200.10
200-Day MA$185.96
Avg Volume (30 day)1.24M
Share Statistics
Outstanding shares, float, and per-share metrics
Shares Outstanding90.83M
Book Value per Share$46.46
Net Cash per Share$30.87
FCF per Share$23.80
Analyst Price Targets & Consensus
Wall Street analyst ratings and 12-month price targets (90 days)
Price Target$241.80
Target Upside/Downside3.22%
Analyst ConsensusStrong Buy
Analyst Count5
Profitability & Financial Performance
Profit margins, return metrics, and earnings analysis
Profit Margins
Profitability margins across income statement
Gross Margin48.19%
EBITDA Margin (ttm)41.97%
EBIT Margin (ttm)37.99%
Operating Margin (ttm)16.61%
Pretax Margin (ttm)28.09%
Profit Margin (ttm)6.49%
FCF Margin (ttm)10.37%
Return on Investment Metrics
ROE, ROA, ROIC, and capital efficiency ratios
Return on Equity (ttm)32.09%
Return on Assets (ttm)4.56%
Return on Invested Capital (ttm)12.62%
Return on Capital Employed (ttm)31.42%
Income Statement (TTM)
Trailing twelve months revenue and earnings
Revenue20.86B
Gross Profit10.05B
Operating Income3.46B
Pretax Income5.86B
Net Income1.35B
EBITDA8.75B
EBIT7.92B
Diluted EPS$15.28
Cash Flow (TTM)
Operating cash flow and free cash flow metrics
Operating Cash Flow2.48B
Capital Expenditures316.00M
Free Cash Flow2.16B
Growth Rates (YoY)
Year-over-year growth metrics
Revenue Growth0.92%
Financial Health & Dividends
Balance sheet analysis, debt ratios, and dividend metrics
Assets & Cash
Total assets and cash positions
Total Assets (mrq)29.68B
Cash & Securities (mrq)2.88B
Net Cash (mrq)2.80B
Net Cash per Share$30.87
Debt & Liabilities
Liabilities, debt, equity, and working capital
Total Debt (mrq)13.17B
Working Capital (mrq)3.39B
Total Equity (mrq)4.22B
Book Value per Share$46.46
Liquidity & Leverage
Liquidity, leverage, and debt coverage ratios
Current Ratio (mrq)1.76
Quick Ratio (mrq)1.68
Debt/Equity (mrq)3.12
Debt/EBITDA (ttm)1.50
Debt/FCF (ttm)6.09
Dividend History & Payout Analysis
Dividend yield, payout ratios, and growth metrics
Dividend per Share (TTM)$0.00
Dividend Yield0.00%
Payout Ratio (Earnings)0.00%
Ex-Dividend DateMar 13, 2000
Pay DateMar 24, 2000
Yield Metrics
Earnings, FCF, buyback, and shareholder yields
Earnings Yield6.36%
FCF Yield10.16%
Buyback Yield6.75%
Total Shareholder Yield6.75%
Financial Health Scores
Risk assessment and quality metrics
Altman Z-Score2.55
Piotroski F-Score4/9
Fair Value & Intrinsic Value
Lynch fair value, Graham number, and valuation models
Graham Number$126.38
Graham Upside/Downside-46.05%